BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Jun 8, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-06-06

Reporting Person: Wood Mark (VP, Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-06-06	Common Stock	M	1250	—	Acquired	20461	Direct
2011-06-07	Common Stock	S	456	$27.4569	Disposed	20005	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-06-06	Restricted Stock Units	$0	M	1250	Disposed		Common Stock (1250)	Direct

Footnotes

F1: Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted May 22, 2008.

F2: Transaction made pursuant to a Rule 10b5-1 Trading Plan executed on September 7, 2010.

F3: The price in Column 4 is a weighted average price. The prices actually received ranged from $27.39 to $27.57. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: Original grant of restricted stock units vest 1/4th each on July 7, 2008, June 7, 2009, June 7, 2010 and June 7, 2011.